![](/img/cover-not-exists.png)
746 NARLAPREVIR AND PEGINTERFERON ALFA-2B FOR 2 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS, FOLLOWED BY PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR 24/48 WEEKS: FINAL RESULTS
J. de Bruijne, J.F. Bergmann, C.J. Weegink, R. Molenkamp, J. Schinkel, M.A. Treitel, E.A. Hughes, A. van Vliet, R.J. de Knegt, H.W. Reesink, H.L.A. JanssenVolume:
52
Year:
2010
Language:
english
DOI:
10.1016/s0168-8278(10)60748-9
File:
PDF, 69 KB
english, 2010